ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,587.00
0.23%
S&P ASX All Technology
2,972.40
0.12%
Brent Oil
83.84
0.36%
US Dollar vs AUD
1.52483
-0.40%
Bitcoin
59,142.05
1.55%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Agile Therapeutics Inc (AGRX)

  7. Agile Therapeutics Inc (AGRX) News

AGRX

Agile Therapeutics (AGRX)

Agile Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AGRX
DateTimeSourceHeadlineSymbolCompany
28/03/202423:05GlobeNewswire Inc.Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:AGRXAgile Therapeutics Inc
26/03/202407:30GlobeNewswire Inc.Agile Therapeutics Announces Delisting from NasdaqNASDAQ:AGRXAgile Therapeutics Inc
21/03/202421:35GlobeNewswire Inc.Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024NASDAQ:AGRXAgile Therapeutics Inc
20/03/202423:15GlobeNewswire Inc.Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024NASDAQ:AGRXAgile Therapeutics Inc
13/03/202422:31GlobeNewswire Inc.Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan ExecutionNASDAQ:AGRXAgile Therapeutics Inc
24/02/202408:57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AGRXAgile Therapeutics Inc
24/02/202408:55Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AGRXAgile Therapeutics Inc
23/02/202401:01GlobeNewswire Inc.Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross ProceedsNASDAQ:AGRXAgile Therapeutics Inc
16/02/202408:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
16/02/202408:30GlobeNewswire Inc.Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance UpdateNASDAQ:AGRXAgile Therapeutics Inc
14/02/202412:02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
08/02/202408:51Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
07/02/202402:14Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
06/02/202401:21Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
03/02/202408:27Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
24/01/202401:29GlobeNewswire Inc.The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without CostNASDAQ:AGRXAgile Therapeutics Inc
21/12/202300:00Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
13/12/202300:01GlobeNewswire Inc.Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage RequirementNASDAQ:AGRXAgile Therapeutics Inc
12/12/202309:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:AGRXAgile Therapeutics Inc
07/12/202300:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
05/12/202300:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
10/11/202308:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AGRXAgile Therapeutics Inc
10/11/202300:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
10/11/202300:05GlobeNewswire Inc.Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:AGRXAgile Therapeutics Inc
26/10/202323:05GlobeNewswire Inc.Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023NASDAQ:AGRXAgile Therapeutics Inc
05/10/202307:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGRXAgile Therapeutics Inc
05/10/202307:30GlobeNewswire Inc.Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AGRXAgile Therapeutics Inc
03/10/202307:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
29/09/202306:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
05/09/202322:05GlobeNewswire Inc.Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AGRXAgile Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AGRX

Your Recent History

ASX
XAO
Australian SE All Ordina...
ASX
CSL
CSL
COIN
BTCUSD
Bitcoin
NYSE
DIS
Walt Disney
NASDAQ
GOOGL
Alphabet
ASX
XMM
S&P ASX 300 Metals and M...
NYSE
XOM
Exxon Mobil
ASX
NCM
Newcrest Mining
FX
EURAUD
Euro vs AUD
ASX
BHP
BHP
ASX
MQG
Macquarie
NYSE
KO
Coca Cola
FX
AUDCAD
AUD vs CAD
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
RIO
Rio Tinto
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved